Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 196 entries
View as:

Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT05450770 Org: User:
Start: 11/01/24 End: 11/01/24 Due: 11/01/25

A Chronological Study of the Formation of HIV Cellular Reservoirs Through the Expression of Surface Markers on CD4 + T Lymphocytes, Including CD32a

Phase: N/A Priority: Normal
NCT ID: NCT03298360 Org: User:
Start: 06/28/18 End: 06/25/20 Due: 06/25/21

National Cohort of Children Born to HIV-positive Mothers

Phase: N/A Priority: Normal
NCT ID: NCT03306251 Org: User:
Start: 06/30/05 End: 03/31/23 Due: 03/31/24

the ANRS CO21 " Extreme " Cohort (CODEX)

Phase: N/A Priority: Normal
NCT ID: NCT01520844 Org: User:
Start: 02/29/12 End: 09/30/23 Due: 09/30/24

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

Phase: N/A Priority: Normal
NCT ID: NCT05813964 Org: User:
Start: 06/05/24 End: 05/31/27 Due: 05/31/28

Reducing Antiretroviral Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04051970 Org: User:
Start: 11/27/19 End: 03/01/24 Due: 03/01/25

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Phase: N/A Priority: Normal
NCT ID: NCT01255371 Org: User:
Start: 03/31/12 End: 12/31/14 Due: 12/31/15

ANRS 12392 Sanu Gundo

Phase: N/A Priority: Normal
NCT ID: NCT04482010 Org: User:
Start: 11/29/20 End: 12/28/22 Due: 12/28/23

Gut-Associated Lymphocyte Trafficking

Phase: N/A Priority: Normal
NCT ID: NCT02906137 Org: User:
Start: 02/06/17 End: 02/25/20 Due: 02/25/21

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01066962 Org: User:
Start: 08/31/10 End: 10/31/13 Due: 10/31/14

HIV-1 Non-group M in Cameroon : Study of Genotypic and Phylogenetic Diversity (OBSOCAM)

Phase: N/A Priority: Normal
NCT ID: NCT06913959 Org: User:
Start: 06/30/25 End: 07/01/27 Due: 07/01/28

Negative Serology by Immunoenzymatic Test (EIA) in HIV-infected Children Treated Early With Antiretroviral in the ANRS-Pediacam Study: Pathophysiological Mechanisms

Phase: N/A Priority: Normal
NCT ID: NCT06302933 Org: User:
Start: 05/02/24 End: 08/30/25 Due: 08/30/26

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT04145258 Org: User:
Start: 02/07/21 End: 04/30/26 Due: 04/30/27

Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention

Phase: N/A Priority: Normal
NCT ID: NCT03870438 Org: User:
Start: 12/14/19 End: 10/31/22 Due: 10/31/23

Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure. (MULTIVIR2025)

Phase: N/A Priority: Normal
NCT ID: NCT06842706 Org: User:
Start: 04/30/25 End: 03/31/26 Due: 03/31/27

Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00265642 Org: User:
Start: 10/31/06 End: 11/30/13 Due: 11/30/14

An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection

Phase: N/A Priority: Normal
NCT ID: NCT02972450 Org: User:
Start: 02/20/19 End: 07/11/19 Due: 07/11/20

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)

Phase: N/A Priority: Normal
NCT ID: NCT03537196 Org: User:
Start: 11/13/18 End: 12/30/22 Due: 12/30/23

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living with HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT06203132 Org: User:
Start: 01/27/25 End: 11/30/27 Due: 11/30/28

Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT01715103 Org: User:
Start: 07/31/13 End: 01/31/15 Due: 01/31/16

Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal

Phase: N/A Priority: Normal
NCT ID: NCT03215732 Org: User:
Start: 10/19/17 End: 07/31/19 Due: 07/31/20

Evaluation of Raltegravir During the Third Trimester of Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT02099474 Org: User:
Start: 06/30/14 End: 04/30/17 Due: 04/30/18

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01332955 Org: User:
Start: 04/30/11 End: 09/30/13 Due: 09/30/14

Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns

Phase: N/A Priority: Normal
NCT ID: NCT05017558 Org: User:
Start: 03/31/22 End: 12/31/23 Due: 12/31/24

HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)

Phase: N/A Priority: Normal
NCT ID: NCT04044586 Org: User:
Start: 09/01/19 End: 03/01/20 Due: 03/01/21